Saturday, January 18, 2020

FW: (LML) Dapsone allergy and MB treatment

 

Leprosy Mailing List – January 18,  2020

Ref.:   (LML) Dapsone allergy and MB treatment

From:  Ben Naafs, Munnekeburen, the Netherlands


Dear Pieter, 

 

Thanks to Dr. Shen Jianping for his very relevant question regarding Dapsone allergy and multidrug MB treatment (LML, January 6, 2020). I think it is good that all Chinese leprosy patients are checked for the 1301 gene-locus. Dapsone Syndrome is a terrible occurrence. But as pointed out having this gene locus does not always lead to the Dapsone syndrome.

 

Treating Multibacillary patients with only 2 drugs was at start of the MDT considered insufficient with no clinical evidence. But we know now that highly positive patients in a high endemic area after many years may relapse. Even in non-endemic area's as the Netherlands, we have seen relapses we considered from persisters. We still do not know how we can eradicate those persisters. Except maybe with a preventive treatment. Then still resistance may have occurred.

 

The paper from Yunnan fits in with my own feeling. PB as WHO advised will be treated with 3 drugs with the mentioned locus they will get 2 drugs. Which most likely will be enough. But my feeling is Rifampicine with Clofazimine together is not enough for MB patients. Without proper evidence, the WHO has neither, I would add minocycline or another 3rd drug. And then still we may have relapses.

 

My excuses for this personal answer, I think we have no sufficient evidence from trials and worse no good follow up.

 

We wish you a good Chinese New Year

 

Dr Ben Naafs

Dermatovenerologist

Leprologist since 1973. Ethiopia, Zimbabwe, The Netherlands, Brazil. Tanzania


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/c6c2b349-6be1-4ad8-b4d1-2459d65ce7a9%40googlegroups.com.

No comments: